Toggle Health Problems and D

Why Isn’t Everyone Supplementing with Vitamin D - LEF Jan 2016

Nice brief introduction to vitamin D

 Download the PDF from VitaminDWiki
By Life Extension Foundation
Discusses a score of diseases
"Life Extension® has been writing about the health benefits of vitamin D for many decades."
"Vitamin D dosing in the range of 5,000 to 8,000 IU each day should be taken with a meal for better absorption."


I have been a LEF subscriber for about 20 years
I first learned of the benefits of Vitamin D thru LEF
During 2015 the magazine probably averaged 3 articles/mentions of vitamin D each month
I buy my vitamin D test via LEF - they have a very low price - but have to go to a lab for the blood draw
I buy LEF Super K to get a variety of vitamin K types
    Henry Lahore, admin of VitaminDWiki

LEF References

  1. Available at: http://www.lifeextension.com/magazine/2010/1/startling-findings-about-vitamin-d-levels-in-life-extension- members/page-01. Accessed October 8, 2015.
  2. Available at: http://www.lifeextension.com/magazine/2012/ss/vitamin-d-blood-levels/page-01. Accessed October 8, 2015.
  3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin EndocrinolMetab. 2011 ;96(7): 1911-30.
  4. Wu K, Feskanich D, Fuchs CS, et al. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007;99(14): 1120-9.
  5. Edlich R, Mason SS, Chase ME, et al. Scientific documentation of the relationship of vitamin D deficiency and the development of cancer. J Environ Pathol Toxicol Oncol. 2009;28(2): 133-41.
  6. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19(7):468-83.
  7. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174-80.
  8. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340-9.
  9. Szabo B, Merkely B, Takacs I. The role of vitamin D in the development of cardiac failure. Orv Hetil.2009; 150(30): 1397-402.
  10. Gouni-Berthold I, Krone W, Berthold HK. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol. 2009;7(3):414-22.
  11. Suzuki Y, Ichiyama T, Ohsaki A, et al. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol. 2009;113(1-2):134-8.
  12. Dietrich T, Nunn M, Dawson-Hughes B, et al. Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. Am J Clin Nutr. 2005;82(3):575-80.
  13. Xia JB, Wang CZ, Ma JX, et al. Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation. Zhonghua Yi Xue Za Zhi. 2009;89(8):514-8.
  14. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. New Engl JMed. 2009;360(18):1912-4.
  15. Williams S, Heuberger R. Outcomes of vitamin D supplementation in adults who are deficient and critically ill: A Review of the Literature. Am J Ther. 2015.
    Publisher charges for PDF
  16. Vogt S, Decke S, de Las Heras Gala T, et al. Prospective association of vitamin D with frailty status and all-cause mortality in older adults: Results from the KORA-Age Study. PrevMed. 2015;73:40-6.
  17. Lo Gullo A, Mandraffino G, Bagnato G, et al. Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number. PLoS One. 2015;10(8):e0134602.
  18. Moraes RB, Friedman G, Wawrzeniak IC, et al. Vitamin D deficiency is independently associated with mortality among critically ill patients. Clinics (Sao Paulo). 2015;70(5):326-32.
  19. Dickerson RN, Berry SC, Ziebarth JD, et al. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness. Nutrition. 2015;31(10):1219-23.
  20. Brook K, Camargo CA, Christopher KB, et al. Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Ann Intensive Care. 2015;5(1):23.
  21. Higgins DM, Wischmeyer PE, Queensland KM, et al. Relationship of vitamin D deficiency to clinical outcomes in critically ill patients. JPEN J Parenter Enteral Nutr. 2012;36(6):713-20.
  22. Zajic P, Amrein K. Vitamin D deficiency in the ICU: a systematic review. Minerva Endocrinol. 2014;39(4):275-87.
  23. Available at: http://www.cdc.gov/stroke/facts.htm. Accessed October 8, 2015.
  24. Available at: http://www.uhnj.org/stroke/stats.htm. Accessed October 8, 2015.
  25. Available at: http://www.ninds.nih.gov/disorders/stroke/stroke rehabilitation.htm. Accessed October 8, 2015.
  26. Available at: http://consumer.healthday.com/cardiovascular-health-information-20/misc-stroke-related-heart-news-360 /low-vitamin-d-levels-in-stroke-survivors-a-bad-sign-study-finds-696093.html. Accessed October 8, 2015.
  27. Turetsky A, Goddeau RP, Jr., Henninger N. Low serum vitamin D is independently associated with larger lesion volumes afterischemic stroke. JStroke Cerebrovasc Dis. 2015;24(7):1555-63.
  28. Park KY, Chung PW, Kim YB, et al. Serum vitamin D status as a predictor of prognosis in patients withacute ischemic stroke. Cerebrovasc Dis. 2015;40(1-2):73-80.
  29. Majumdar V, Prabhakar P, Kulkarni GB, et al. Vitamin D status, hypertension and ischemic stroke: a clinical perspective. J Hum Hypertens. 2015;29(11):669-74.
  30. Hartog JW, Voors AA, Schalkwijk CG, et al. Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur Heart J. 2007;28(23):2879-85.
  31. Xu W, Qiu C, Winblad B, et al. The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes. 2007;56(1):211-6.
  32. Noto H, Osame K, Sasazuki T, et al. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications. 2010;24(5):345-53.
  33. Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. DiabetolMetab Syndr. 2013;5(1):8.
  34. Oh YS, Jun HS. Role of bioactive food components in diabetes prevention: effects on Beta-cell function and preservation. Nutr Metab Insights. 2014;7:51-9.
  35. Yang Z, Liu F, Qu H, et al. 1, 25(OH)2D3 protects beta cell against high glucose-induced apoptosis through mTOR suppressing. Mol Cell Endocrinol. 2015;414:111-9.
  36. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343(13):938-52.
  37. Available at: http://www.healthline.com/health/multiple-sclerosis/facts-statistics-infographic. Accessed October 13, 2015.
  38. Mokry LE, Ross S, Ahmad OS, et al. Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med. 2015;12(8):e1001866.
  39. Available at: https://clinicaltrials.gov/ct2/show/study/NCT01285401?term=NCT01285401&rank=1. Accessed October 13, 2015.
  40. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009;132(Pt 5):1146-60.
  41. Guo Y, Xu F, Lu T, et al. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38(7):904-10.
  42. Eder K, Baffy N, Falus A, et al. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58(11):727-36.
  43. Duggan C, de Dieu Tapsoba J, Mason C, et al. Effect of vitamin D3 supplementation in combination with weight loss on inflammatory biomarkers in postmenopausal women: a randomized controlled trial. Cancer PrevRes (Phila). 2015;8(7):628-35.
  44. McGrath J. Does ‘imprinting’ with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses. 2001;56(3):367-71.
  45. Morales E, Julvez J, Torrent M, et al. Vitamin D in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology. 2015;26(4):458-65.
  46. Hawes JE, Tesic D, Whitehouse AJ, et al. Maternal vitamin D deficiency alters fetal brain development in the BALB/c mouse. Behav Brain Res. 2015;286:192-200.
  47. Cui X, Pertile R, Liu P, et al. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience. 2015;304:90-100.
  48. Brunvand L, Quigstad E, Urdal P, et al. Vitamin D deficiency and fetal growth. Early Hum Dev. 1996;45(1-2):27-33.
  49. Kesby JP, Cui X, Burne TH, et al. Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia. Front CellNeurosci. 2013;7:111.
  50. Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab. 2014;99(10):3863-72.
  51. Shivakumar V, Kalmady SV, Amaresha AC, et al. Serum vitamin D and hippocampal gray matter volume in schizophrenia. Psychiatry Res. 2015;233(2):175-9.
  52. Yuksel RN, Altunsoy N, Tikir B, et al. Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Ther Adv Psychopharmacol. 2014;4(6):268-75.
  53. Available at: https://www.washingtonpost.com/blogs/fact-checker/wp/2013/10/23/does-the-united-states-have-128- trillion-in-unfunded-liabilities. Accessed October 13, 2015.
Why Isn’t Everyone Supplementing with Vitamin D - LEF Jan 2016        
4792 visitors, last modified 31 Dec, 2015,
(Cached) Printer Friendly Follow this page for updates

Attached files

ID Name Comment Uploaded Size Downloads
6242 Why Isn’t Everyone Supplementing.pdf PDF 2016 admin 12 Dec, 2015 20:00 468.31 Kb 1148